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Background: The classic sweat test (CST) is the golden standard for cystic fibrosis (CF) diagnosis. Then, our aim was
compare the production and volume of sweat, and side effects caused by pulsed direct current (PDC) and constant
direct current (CDC). To determine the optimal stimulation time (ST) for the sweat collection. To verify the PDC as
CF diagnosis option.
Methods: Prospective study with cross-sectional experimental intervention. Experiment 1 (right arm): PDC and CDC.
ST at 10 min and sweat collected at 30 min. Currents of 0.5; 0.75; 1.0 and 1.5 mA and frequencies of 0, 200, 1,000
and 5,000 Hz applied. Experiment 2 (left arm): current of 1.0 mA, ST at 5 and 10 min and sweat collected at 15 and
30 min with frequencies of 0; 200; 1,000 and 5,000 Hz applied Experiments 1 and 2 were performed with current
density (CD) from 0.07 to 0.21 mA/cm2. Experiment 3: PDC was used in typical CF patients with two CFTR mutations
screened and or with CF diagnosis by rectal biopsy and patients with atypical CF.
Results: 48 subjects (79.16% female) with average of 29.54 ± 8.87 years old were enrolled. There was no statistical
difference between the interaction of frequency and current in the sweat weight (p = 0.7488). Individually, positive
association was achieved between weight sweat and stimulation frequency (p = 0.0088); and current (p = 0.0025).
The sweat production was higher for 10 min of stimulation (p = 0.0023). The sweat collection was better for 30 min
(p = 0.0019). The skin impedance was not influenced by ST and sweat collection (p > 0.05). The current frequency
was inversely associated with the skin impedance (p < 0.0001). The skin temperature measured before stimulation
was higher than after (p < 0.0001). In Experiment 3 (29 subjects) the PDC showed better kappa index compared to
CDC (0.9218 versus 0.5205, respectively).
Conclusions: The performance of the CST with CDC and PDC with CD of 0.14 to 0.21 mA/cm2 showed efficacy in
steps of stimulation and collection of sweat, without side effects. The optimal stimulation time and sweat collection
were, respectively, 10 and 30 min.
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The first report of increased levels of sodium and chloride
on sweat in cystic fibrosis (CF, MIM #219700) patients
was published in 1953 [1]. Later, Gibson and Cooke [2]
described a method of cholinergic stimulation with pilo-
carpine iontophoresis on the skin to facilitate the dosage
and stimulation of the sweat electrolytes. This method is
known as the classic sweat test (CST), and still is consid-
ered the golden standard for CF diagnosis [3,4].
In the sweat gland ducts, chloride ions (Cl-) are reab-
sorbed by the CFTR (cystic fibrosis transmembrane
regulator) [5]. Then, in health subjects, the normal
concentration of sweat chloride levels are minor than
30 mmol/L [6,7]. CF patients show in the distal ducts
of sweat gland, absence or defect of CFTR protein, and
reduction of Cl- reabsorption [8,9].
Two distinct CST confirms CF diagnosis when sweat
Cl- levels are greater than 60 mmol/L. The sweat test by
European perspective is divided by ranges considering
the following groups: minor than 30 mmol/L (normal
range), 30 to 60 mmol/L (intermediate range), higher
than 60 mmol/L [6,7,10].
The CST implementation presents many difficulties. It
is divided into three stages: stimulation, collection and
electrolytes measurement [11]. During the stimulation
fase can occur: low amount of sweat production, difficulties
to immobilize children, stress, burns, pain, hives, redness
and skin irritation, when the current density (CD) is applied
over than 0.5 mA/cm2. Electric shock and skin injuries may
occur when the metal electrode is in direct contact with
the skin, in case of misuse. In collection stage can occur:
contamination, sample evaporation and inadequate time
in the sweat production. For electrolytes dosage the prob-
lems include a lack of specialized professional to perform
the sweat analysis and variability of equipment brands for
electrolytes measurement [2,11,12].
Taking into account the difficulties in CST realization,
to standardize the CST in Brazil has been a great problem.
Sweat stimulation equipments are, principally, constructed
by CF reference centers and have no authorization from
the national health surveillance agency. Recently, the
Brazilian government authorized the Macroduct® (Wescor®,
USA, Utah) system for the CST [13-15]. However, due to
the difficulties in purchasing and maintaining the devices,
few Brazilian laboratories have this equipment, with no
standard use.
In the literature, the constant direct current (CDC) is
used to induce the sweat by iontophoresis. There are re-
ports on the efficiency in the substances delivery through
the skin by pulsed direct current (PDC), without causing
burning and discomfort risk when compared to CDC. On
the other hand, some authors have found greater, smaller
or equal efficacy between CDC and PDC for substances
delivery into the skin by iontophoresis [16-19].Sweat test made with gauze or filter paper use the mini-
mum amount of 75 mg of sweat (classical experiment by
Gibson and Cooke), while the sweat collected by serpen-
tine or plastic capillary tube is 15 μL. After collecting,
sweat samples are sent to dosage the electrolytes concen-
tration [2,6,7,13].
The aim of the present study was to compare the
sweat weight and side effects by PDC and CDC and de-
termine the optimal stimulation time of sweat collection
in healthy individuals. In addition, we checked PDC use
for CF diagnosis in patients with and without confirmed
CF diagnosis, who had previously performed CST with
CDC.
Methods
Experimental study, with prospective cross-sectional
intervention in subjects with and without CF disease.
For the CST, the sweat-inducing device developed by
the Centre of Biomedical Engineering University was used.
The iontophoresis device is portable, easy to use and able
to select PDC and CDC, with triangular waveform, fre-
quency from zero to 5,000 Hz, maximum current of
5 mA, software settings and data acquisition support, and
two electrodes comprising 70% copper and 30% zinc with
diameter of 30 mm. The battery powered was used in the
sweat test device. Sweat tests were performed with 0.5%
pilocarpine (refrigerated when not in use).
The Research Ethics Committee of the State University
of Campinas (#80430/2012) approved the project. All
subjects read and signed an informed consent.
The room temperature was stabilized at 25°C and
the applied CD was calculated according to the formula
P = I/S; P = density, I = current and S = electrode area.
The variables gender, ethnicity, age and body mass
index (BMI) were considered. The BMI calculation was
performed by the formula: weight (kg)/height2 (m) [20].
Three sets of experiments were performed:
Experiment 1: right arm of healthy subjects (randomly
selected frequency and intensity of the current)
Objective: to compare the sweat weight and impedance
of the electrode assembly, gauze and skin between CDC
and PDC. We used stimulation time of 10 min and sweat
collection of 30 min. We applied currents of 0.5; 0.75; 1.0
and 1.5 mA, frequency of 0, 200, 1,000 and 5,000 Hz. Data
collection was done along six months.
Experiment 2: left arm of healthy subjects (randomly
selected stimulation time, collection time and current
frequency)
Objective: to compare the sweat weight and impedance
of the electrode assembly, gauze and skin with different
stimulation and collection times. Were applied fixed
current of 1 mA in the tests. Stimulation time of five and
Table 1 Clinical characterization of subjects enrolled in
the experiments 1, 2 and 3
Variable Sample size Distribution
Experiment 1 and
2 subjects
Sex (masculine) 48 18/48 (37.5%)
Etnicity (Caucasian) 48 35/48 (72.9%)
Age* 48 29.54 ± 6.51; 27 (20 – 55)
Height* 48 167.92 ± 8.74; 166 (150 – 191)
Weight* 48 67.21 ± 9.77; 65 (50 – 95)
Body mass index* 48 23.83 ± 2.56; 23.22 (18.14 – 34.48)
Experiment 3
subjects
Sex (masculine) 29 10/29 (34.5%)
Etnicity (Caucasian) 29 25/29 (86.2%)
Age* 29 24.37 ± 12.106; 21 (6 – 46)
Height* 29 1.56 ± 0.154; 1.58 (1.22 – 1.87)
Weight* 29 50.078 ± 13.81; 52 (26.8 – 76.6)
Body mass index* 29 20.21 ± 3.60; 19.71 (13.20 – 29.65)
*Mean ± standard deviation; median (minor and major values).
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0, 200, 1,000 and 5,000 Hz. Data collection was done
along six months.
Experiment 3: right arm of patients with classical and
atypical CF (PDC current of 1 mA, frequency of 1,000 Hz,
stimulation time of 10 min and collection time of 30 min)
Objective: to compare the sweat weight and chloride
levels by PDC and CDC. Compare the CF diagnosis by
CST (considering the PDC and CDC) with the results of
rectal biopsy [21] and CFTR mutations. Data collection
was done during two days for all subjects enrolled. All
the subjects enrolled are attended in CF reference center
considering the clinical symptoms and comorbidities
related with CF disease. The subjects performed the
CST – CDC before the study, and PDC during the
study. The data was compare with CFTR mutations
and CFTR expression and function (determined by rectal
biopsies).
The CST was performed in three steps: stimulation,
collection and measurement, according to Gibson and
Cooke [2], with a distance of five cm between the
electrodes.
We evaluated the discomfort in the first, fifth and
last minute by the visual analog scale (VAS) (Additional
file 1) [22].
The impedance of the set composed by electrode,
gauze and skin during the stimulation time was calculated
by Ohm’s law [Z = VRMS / IRMS (Ω)]; Z = impedance (Ω);
VRMS = voltage measured by RMS (V); IRMS = current
measured by RMS (A).
To collect the sweat were used two filter paper of
17.5 cm2 covered with plastic and bandage crepe filter.
In classical Gibson and Cooke test, the 75 mg sweat
criteria was considered, being 1 g (sweat)/m2 (sweat
collection area)/min (collection time) in a area of 5.5 cm
diameter filter paper. To simulate this value, a sweat
weight of 54 mg was considered in our data.
Manual titration and flame fotometometria were used
to analyze chloride and sodium concentration in mEq/L,
respectively [2,6,7]. Quality controls (positive cases of
sweat tests and health subjects) were used to perform
the chloride and sodium dosage.
Each subject performed Experiment 1 and Experiment
2 at the same time. The Experiment 3 was performed
after the conclusion of the Experiments 1 and 2.
Statistical analysis
SAS (Statistical Analysis System) for Windows, vs 9.2.
(SAS Institute Inc, 2002–2008, Cary, NC, USA) was used
for data analysis. Graphs were designed using SPSS
(Statistical Package for the Social Sciences) vs 22.0 (IBM®,
Armonk, NY, USA) and Medcalc vs 13.2.2 (MedCalc Soft-
ware, Acacialaan 22, B-8400 Ostend, Belgium).Numerical variables are shown by position and dis-
persion measures. Analysis of variance (ANOVA) for
repeated measures was used to compare data parameters.
We applied the transformation of posts due to the lack of
normal distribution.
Spearman’s correlation was applied to correlate the
chloride values and sweat weight for CDC and PDC of
CF patients, atypical CF patients, and healthy subjects.
Kappa index was performed to measure the concordance
among data.
The significance level was set at α = 0.05 and β = 0.08.
Results were presented in tables and graphs.
Results
The study enrolled 77 subjects, 48 healthy individuals
(79.16% female) with an average of 29.54 ± 8.87 years
and 29 patients, with classical and atypical CF, with an
average age of 24.37 ± 12.11 years. Table 1 shows the
features from the studied population including the ex-
periments 1, 2 and 3. CFTR mutation frequency and
mutation characterization are described, respectively,
in the Additional files 2 and 3.
Experiment 1 – testing intensity and frequency of the
current for sweat test
There was no statistical difference between the interaction
of frequency and current for the sweat weight (p = 0.7488)
(Table 2, Figure 1).
Considering the CST by Gibson and Cooke, 16.7%
(3/24) of the subjects in the Experiment 1 had no
Table 2 Sweat weight (mg) at different frequencies and
current
Frequency (Hz)* Current (mA)#
0.5 0.75 1 1.5
0 (CDC) 167 ± 5.9 173 ± 12.2 236 ± 3.6 328 ± 11.8
200 78 ± 2.0 91 ± 3.2 189 ± 5.5 150 ± 4.2
1000 146 ± 8 254 ± 11.1 300 ± 13.7 226 ± 16.6
5000 136 ± 3.2 125 ± 1.2 221 ± 9.0 212 ± 5.7
CDC, constant direct current; Hz, Hertz, mA, milliampere. *For the frequency
analysis and sweat weight, p-value = 0.0088; #For the current and sweat
weight, p-value = 0.0025; for interaction between current, frequency and sweat
weight, p-value = 0.7488.
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sus 4.2% (1/24) for high frequencies, but no significant
association was achieved (p = 0.348). However, consid-
ering the 54 mg sweat criteria in our data, all the sub-
jects sweated correctly to perform the sweat test.
There was association from sweat weight with current
frequency (p = 0.0088, Figure 1b) and with current inten-
sity applied (p = 0.0025, Figure 1a).C
A B
Figure 1 Association with the sweat weight, current and frequency. A
and sweat weight (p = 0.0025). C. Interaction among current, frequency andExperiment 2 – testing stimulation time, collection time
and the frequency of the current
High sweat production occurred with 10 min of stimula-
tion compared to 5 min (p = 0.0023), and 41.7% (10/24)
of subjects had insufficient sweat weight (< 54 mg) in
5 min versus 4.2% (1/24) for 10 min (p = 0.002).
The collection time of 30 min allowed greater sweat
weight than 15 min (p = 0.0019) (Table 3, Figure 2),
and 37.58% (9/24) of subjects had insufficient sweat
weight (< 54 mg) in 15 min versus 8.3% (2/24) for
30 min (p = 0.018).
The skin impedance was not influenced by the time
of sweat stimulation (p = 0.2433), and sweat collection
(p = 0.2697). There was no influence of interaction be-
tween stimulation and collection time (p = 0.1204).
The current frequency was associated inversely with
skin impedance (p < 0.0001). Moreover, the current fre-
quency showed no association with the collection time
(p = 0.7578), as well with the stimulation time (p = 0.5898).
There was no association between stimulation and collec-
tion time (p = 0.9320) (Tables 4 and 5).. Current values and sweat weight (p = 0.0088). B. Frequency values
sweat weight (p = 0.7488).
Table 3 Sweat weight (mg) for frequencies and stimulation
and collection time of sweat, with fixed current of 1 mA
Frequency
(Hz)*
Stimulation Time x time of collection of the sweat#
10 × 30 10 × 15 5 × 30 5 × 15
0 (CDC) 160 ± 5.1 76 ± 4.8 18 ± 0.204 41 ± 0.9
200 137 ± 3.1 118 ± 14.4 147 ± 0.04 77 ± 3.9
1000 222 ± 7.4 138 ± 7.0 83 ± 0.09 80 ± 4.9
5000 267 ± 7.3 164 ± 8.8 111 ± 0.03 69 ± 6.3
CDC, constant direct current; Hz, Hertz, mA, milliampere. *In the analysis
considering stimulation time, p-value = 0.0023 (10 > 5 min); #In the analysis
considering the collection time, p-value = 0.0019 (30 > 15 min). For frequency
(p = 0.4672), frequency + stimulation time (p = 0.3046), frequency + collection
time (p = 0.6723), time of stimulus + collection time (p = 0.7131) and frequency
+ collection time + stimulus time (p = 0.7322), there was no
statistical association.
Figure 2 Association of sweat weight with the stimulation and collec
(p = 0.5898). B. Collection time and sweat weight (p = 0.9320). C. Stimulatio
and collection time, frequency and sweat weight (p = 0.7578).
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did not allow comparison between the currents and fre-
quencies, as well, for induction and collection time of
sweat. All controls showed normal levels of chloride and
sodium in sweat test for Experiments 1 and 2. Skin
temperature before stimulation was higher than after
(p < 0.001 in both cases) (Tables 6 and 7). The layer of fat
in the skin assessed by BMI showed no statistical difference
for different frequencies and intensities of the currents, as
well as different stimulation and collection times (p > 0.05).
The CD ranged from 0.07 to 0.21 mA/cm2 (Table 8).
Experiment 3 – classical and atypical CF
Both the CDC (p = 0.006) and PDC (p < 0.001) showed
values consistent with the results of rectal biopsy andtion time and frequency. A. Stimulation time and sweat weight
n and collection time and sweat weight (p = 0.1204). D. Stimulation
Table 4 Impedance data (in Ohm) for frequencies and currents, with a fixed time of 10 min for stimulation and 30 min
for collection
Frequency (Hz)* Current (mA)#
0.5 0.75 1 1.5
0 (CDC) 11303.4 ± 5487.4 11339.3 ± 7507.5 8178.2 ± 2004.9 5685.5 ± 838.5
200 8615.9 ± 4763.1 6086.4 ± 1278.4 5995.3 ± 1592.9 4727.6 ± 562.7
1000 6787.3 ± 1997.8 4387.7 ± 703.0 4198.1 ± 2125.4 2975.2 ± 216.2
5000 6221.3 ± 1962.3 4480.2 ± 450.5 4462.3 ± 1848.2 3226.1 ± 159.6
CDC, constant direct current; Hz, Hertz, mA, milliampere. *In the analysis considering the frequency in relation to the impedance, p-value = 0.0007; #In the analysis
considering the current in relation to the impedance, p-value = 0.0003; for interaction between current and frequency in relation to the impedance, p-value = 0.9871.
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for PDC (Table 9). PDC showed correlation on chloride
levels with CDC (Figure 3A); the same was not true for
the sweat weight (Figure 3B).
Discussion
Although CST is considered the golden standard for the
CF diagnosis [3,4,6,23-25], studies have reported difficul-
ties in performing the test, especially for sweat collection
and electrolyte measurement [26-28]. The sweat stimu-
lation, which is the first step for CST, had few studies
since its implementation and standardization, in 1959,
by Gibson and Cooke [2], and was enhanced in 1983 by
the Webster Sweat inducer system [29], along with the
Wescor Macroduct kit [14,30]. Although the benefits of
iontophoresis have been exploited for other purposes,
the CST has not been changed.
Advantages of the PDC use for the iontophoresis
method over CDC has been demonstrated in studies
with transdermic delivery of substances [18,31-34]. Most
studies showed greater efficacy of the PDC for delivery
of substances into the skin [2,29].
PDC iontophoresisis is less uncomfortable than the
CDC. The depolarization occurs between pulses, pre-
venting epidermal irritation [33,35,36]. In the present
study, in healthy adults, both PDC and CDC were not
annoying. This finding may be due to the use of low CD
used for the PDC and CDC.
The CDC can cause permanent polarization of the
skin during the stimulation, which affects the efficiencyTable 5 Impedance (in Ohm) with frequency data for each dia
of 1 mA
Frequency (Hz) Stimulation
10 × 30 10 ×
0 (CDC) 7656.7 ± 363.1 7527.3 ± 3
200 6765.5 ± 1271.5 5500.3 ±
1000 4822.4 ± 1280.9 3895.6 ±
5000 5317.9 ± 831.4 5330.1 ± 3
CDC, constant direct current; Hz, Hertz, mA, milliampere. *In the analysis considerin
collection, p-value = 0.2697. There was no statistical association for frequency (p <0
(p = 0.7578), time of stimulus + collection time (p = 0.1204) and frequency + stimuluof substance delivery proportionally to the time of appli-
cation of the impedance. This fact can be minimized by
the use of PDC, which is delivered periodically [37,38].
During the phase without stimulation, the skin becomes
depolarized and returns to its initial polarization. How-
ever, Bagniefski and Burnett (1990) showed that greater
depolarization of the skin may decrease the efficiency of
drug delivery, if the frequency is high [18]. In this study,
frequencies of 1,000 to 5,000 Hz were more effective for
pilocarpine delivery and induction of skin perspiration
for the CST compared to lower frequencies of zero to
200 Hz. In our study, all subjects in the Experiment 1
had sufficient sweat weight (< 54 mg) for low and high
frequencies.
Studies with PDC have shown that the waveform influ-
ence on the permeation of the substance into the skin.
Chien and Chen [39] had studied the absorption of
luteinizing- hormone-releasing hormone (LHRH) using
CDC and PDC with different waveforms. Sinusoidal and
rectangular shapes waves were equal to CDC in the flux
of hormone delivery, but the flow for triangular waves
was lower than the CDC. Chien et al. [40] showed that
the flow of drug delivery was efficient for sinusoidal,
trapezoidal and rectangular waves. Hirvonen [41] reported
that the amino acids permeability into skin by CD of
0.5 mA/cm2 and frequency of 2.5 kHz were equal of rect-
angular and sinusial waves. Kanebako [42] showed that
the permeability of the drug tested was better with the use
of PDC with frequencies below 100 Hz and rectangular
wave.de of stimulation and collection time, with fixed current
time* × collection time on sweat test#
15 5 × 30 5 × 15
199.3 9856.1 ± 2517.7 13030.4 ± 2641.0
697.5 5681.9 ± 1075.2 5795.6 ± 1457.4
117.2 4965.8 ± 613.7 4356.3 ± 882.2
088.6 5376.0 ± 1691.7 5873.9 ± 74.6
g time of stimulation, p-value = 0.2433; #In the analysis considering the time of
.0001), frequency + stimulation time (p = 0.5898), frequency + collection time
s time + collection time (p = 0.9320).
Table 6 Frequency and current in relation to the skin
temperature
Frequency (Hz)* Current# Skin temperature Mean Standard
deviation
0 (CDC) 0.5 Before 30.9 0.4
After 29.3 1.2
0.75 Before 31.0 0.3
After 30.6 1.5
1 Before 30.5 0.9
After 30.4 0.7
1.5 Before 31.0 0.3
After 30.6 1.5
200 0.5 Before 30.9 1.2
After 29.6 0.4
0.75 Before 31.5 3.2
After 29.6 1.4
1 Before 31.6 2.3
After 31.2 1.8
1.5 Before 29.4 1.8
After 28.0 1.4
1,000 0.5 Before 31.8 0.9
After 30.7 0.1
0.75 Before 31.3 0.8
After 30.1 0.8
1 Before 30.4 2.3
After 31.3 1.0
1.5 Before 30.8 1.0
After 31.1 2.0
5,000 0.5 Before 31.4 1.6
After 29.3 1.4
0.75 Before 30.2 0.8
After 29.9 0.7
1 Before 31.6 2.1
After 30.3 2.1
1.5 Before 32.8 1.5
After 31.4 0.5
CDC, constant direct current; Hz, Hertz, mA, milliampere. *In the analysis
considering the frequency in relation to skin temperature, p-value = 0.4102;
#In the analysis considering the current in relation to skin temperature,
p-value = 0.5361; for interaction between current and frequency in relation
to skin temperature, p-value = 0.0884. The skin temperature before the
experiment was higher than after, p-value <0.0001.
Table 7 Skin temperature considering frequency, time of
stimulation and collection time, with fixed current of
1 mA
Frequency
(Hz)*,#
Time of
stimulation
Time of
collection
Skin
temperature
Mean Standard
deviation
0 (CDC) 10 min 30 min Before 30.7 0.7
After 30.2 0.8
15 min Before 31.1 2.3
After 29.2 1.6
5 min 30 min Before 29.6 1.4
After 29.3 1.4
15 min Before 31.6 1.7
After 29.2 2.1
200 10 min 30 min Before 31.3 1.1
After 30.4 0.9
15 min Before 32.2 1.3
After 31.3 2.3
5 min 30 min Before 32.3 1.1
After 30.5 1.0
15 min Before 29.3 2.1
After 28.2 3.5
1,000 10 min 30 min Before 29.8 2.1
After 30.1 1.6
15 min Before 31.6 2.0
After 30.9 1.6
5 min 30 min Before 31.3 1.3
After 29.6 0.5
15 min Before 31.9 2.1
After 30.2 1.6
5,000 10 min 30 min Before 31.2 2.8
After 30.8 2.2
15 min Before 33.2 3.0
After 30.9 2.8
5 min 30 min Before 29.9 0.9
After 29.1 0.3
15 min Before 29.9 3.1
After 29.2 2.2
CDC, constant direct current; Hz, Hertz; mA, milliampere. *In the analysis
considering the frequency in relation to skin temperature with the time of
stimulation, p-value = 0.4688; #In the analysis considering the frequency in
relation to skin temperature and collection time, p-value = 0.5770. For interaction
between frequency + stimulation time + collection time, p-value = 0.4682.
The skin temperature was significant higher before the sweat test than after,
p-value <0.0001.
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for granisetron penetration by iontophoresis, and showed
better results in CDC. However, the PDC was considered
less uncomfortable to the skin.
Unlike previous studies, we use the PDC with triangu-
lar waveform and lower current values, which resulted
in adequate sweat weight. In this case, the PDC was auseful procedure to stimulate sweating. This finding
should bring significant benefits, especially for younger
children.
The substance penetration into the skin depends on
the time for the applied current in iontophoresis [43].
Table 8 Current densities (electrode with 3 cm of diameter)
Current (mA) Current density
(mA/cm2)
% volume of sweat
above 54 mg*
0.5 0.07 12/12 (100%)
0.75 0.12 12/12 (100%)
1.0 0.14 12/12 (100%)
1.5 0.21 12/12 (100%)
*The adequate sweat rate was considered for an area practically of 18 cm2
and 30 min of sweat stimulation. For the classical Gibson & Cooke test, the
area considered was related of a 5.5 cm diameter filter paper with 30 min of
stimulation, and the 75 mg criteria was used as the gold standard for
the sweat.
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time of 5 min is capable to stimulate sweating [6,7,13,44].
In our experiments, 10 min of stimulation was able to
induce sweat levels greater than 54 mg, which was bet-
ter than 5 min. This fact is consistent with the first
study inducing sweat iontophoresis [2]. In the present
study, Experiment 2 showed 41.7% (10/24) of subjects
with insufficient sweat weight (< 54 mg) for stimulation
time of 5 min and 4.2% (1/24) for 10 min (p = 0.002). In
this case, the pilocarpine amount increased with the
time of stimulation.
It is well known that sweat is not to be collected longer
than 30 min and not less than 20 min [7,45]. In the
present study, the greatest weight in sweat occurred with
30 min of collection, with CD of 0.14 and 0.21 mA/cm2.
Another important aspect related with the sweat test
is the CD. Wrong CD calculation can cause risk of skin
irritation and burns, therefore the maximum CD
tolerability for the human skin is of 0.5 mA/cm2
[37,38,46,47]. If the CD increases, the flow also increases,
and consecutively the substance delivery. In the study of
Panzade et al. [38], CDC proved to be 3.8 times higher for
substance delivery compared to PDC. Then, the increase
in CD causes an increase in transport of the drug through
the pores of the skin.
In studies that induce sweat with pilocarpine it is not
possible to identify the values of CD. Two guidelineTable 9 Sweat test diagnosis by constant direct and pulsed d
by other methods
Sweat test Groups CF diagnosis*
Typical CF Atypical CF
Constant direct current Typical CF 19 5
Atypical CF 0 4
Total 19 9
Pulsed direct current Typical CF 19 1
Atypical CF 0 9
Total 19 10
*CF diagnosis was performed by CFTR mutation screening and CFTR activity in recta
was done by constant direct current; golden standard diagnosis tool. The pulsed di
and the CFTR mutations and CFTR expression and function by rectal biopsies. All susuggested 0.16 to 0.24 mA/cm2 as suitable CDs to CST
[44,48]. In our study, the CDs between 0.14 to
0.21 mA/cm2 were efficient for pilocarpine delivery
into the skin by iontophoresis, inducing stimulation of
the sweat in 100% of subjects with stimulation time of
10 min and 30 min for collection.
One of the disadvantages of substance delivery into
skin by iontophoresis is the risk of shocks and burns due
to the exposure of an electric current in the skin for long
periods, overdose, lesions at the site of application, alter-
nation of the pH and high current intensities [49,50].
In our study, no subject had significant side effects,
especially due to the low DC used, and indicating great
safety.
The skin has relatively high impedance, which is mainly
associated with the stratum corneum [45,51]. During the
iontophoresis, skin resistance decreases and ion concen-
tration increases in stratum corneum, allowing the sub-
stance delivery during electric current stimulation. At the
end of the current flow, the ion concentration in the skin
returns to physiological levels [52]. There is no evidence
that the current amplitude and stimulation time are asso-
ciated with temporary decrease in impedance, or with re-
duction in skin protection [53]. In the present study, with
the stimulation times of 5 and 10 min, no differences in
the impedance of the electrode, gauze and skin system
were observed.
Bioelectric properties of the skin allow the application
of various forms of electric current. The opposition
offered by the biological tissue is called impedance
present in inter- and extracellular fluid, and the capacitive
reactance of cell membranes. To occur the absorption of
substances through the skin, the electrical current must
overcome the impedance imposed on their flow and reach
the target tissue with sufficient intensity [54,55]. Adipose
tissue is bad conductor of electrical current, causing an
increase in impedance. Although some studies have re-
ported that the frequency variation would not influence
the decrease in skin impedance [18,42,56], Chien et al.irect currents taking into account cystic fibrosis diagnosis
Total p-
value
Cohen’s Kappa
index
Standard
error
Agreement
24 0.006 0.5205 0.1658 Moderate
4
28
20 <0.001 0.9218 0.1851 Almost perfect
9
29
l biopsies by Ussing chamber. The first sweat test performed in the subjects
rect current was done to compare the results with the constant direct current
bjects enrolled have clinical symptoms related with CF disease.
AB
ACF
CCF
ACF
CCF
Figure 3 Pulsed direct current and constant direct current in typical and atypical cystic fibrosis (CF) patients considering the CF
diagnosis and sweat weight. (A) Linear regression for chloride values (mEq/L) taking into account constant direct and pulsed direct currents. In
the graphic is shown the cystic fibrosis diagnosis by CFTR screening and rectal biopsy (in blue color). Twenty-eight subjects were enrolled in the
study. The correlation coefficient was 0.704, 95% CI: 0.449 to 0.853 (p < 0.001). For the same graphic there was no association between the two
sweat tests performed [pulsed direct (92.05 ± 49.28) and constant direct currents (92.80 ± 31.84)] for the values of the Chloride (mEq/L) (p = 0.911).
Pared T-test and Spearman’s correlation test (α = 0.05) were used to study the association and correlation between variables, respectively. (B)
Linear regression for sweat weight values (mg) taking into account constant direct and pulsed direct currents. The cystic fibrosis diagnosis by
CFTR screening and rectal biopsy (in blue color) were shown in the graphic. Twenty-eight subjects were enrolled in the study. The correlation
coefficient was 0.213, 95% CI: −0.190 to 0.554 (p = 0.296). For the same graphic, we observed higher values for the sweat weight on pulsed
direct current (234.86 ± 72.49) than the constant direct current (167.34 ± 25.79) (p = 0.001). For the association was used the test T pared and for the
correlation the Spearman test. α= 0.05. CCF, Classical Cystic Fibrosis; ACF, Atypical Cystic Fibrosis.
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http://www.biomedcentral.com/1471-2466/14/198[40] reported that the skin impedance declined with in-
creasing current frequencies. In our study, PDC with a
frequency of 1,000 Hz showed lower impedance than
CDC, providing adequate sweat production. Addition-
ally, the subjects enrolled did not show high BMI, which
could reduce the pilocarpine delivery and reduction of
sweat production.
Electric current follows the path of minor resistance,
so skin impedance determines its intensity, density
and path, altering the biological responses. Skin im-
pedance changes with the distance between electrodes,
positioning, location of the electric field, amount of
water and number of layers of the stratum corneum.Keratin is the main barrier to the passage of electric
current [57-63].
The interelectrode distance adopted in this study was
of 2 inches and was suitable for sweat stimulation. As
the ambient temperature can lead to decreased hydra-
tion of keratin and thickness of biological tissue, and
thereby influence the impedance increase in skin [64],
the room temperature was maintained at 25°C.
Temperature increase at the electrode is proportional
to the square of CD [61]. This effect was measured on
the place of the skin contact with the electrodes, before
and after stimulation. The applied CD promoted cooling,
and no heating of the electrodes, preventing burns.
Gomez et al. BMC Pulmonary Medicine 2014, 14:198 Page 10 of 11
http://www.biomedcentral.com/1471-2466/14/198Our study showed that, despite the wide CST use for
the CF diagnosis, there is still a field of studies to assess
and maximize the efficiency and effectiveness of stimula-
tion and collection steps. Currently, there is an increasing
frequency of the CST use, especially in younger individ-
uals, due to the implementation of CF newborn screening
in our country. Therefore, we believe that the use of PDC
may be a benefit for infants in the first year of life due to
lower risk and discomfort associated.
Conclusion
CST with CDC or PDC using CD of 0.07 to 0.21 mA/cm2
showed efficacy in stimulation and collection steps of
sweat test without side effects and adequate sweat weight
to perform the CST, with a greater concordance of CF
diagnosis for PDC sweat test.
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